Heat-inactivated C. pneumoniae organisms are not atherogenic

Molecular and Cellular Biochemistry

Volumn 260, Issue 1, 2004, Pages 147-152

  Sharma, Jyotika ^a   Niu, Yuhong ^b   Ge, Jianbo ^b   Pierce, Grant N ^c   Zhong, Guangming ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b FUDAN UNIVERSITY   (China)

^c UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Atherogenesis; Chlamydia pneumoniae; Heat inactivation; LDLR murine model

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BACTERIAL INFECTION; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; HEAT TREATMENT; MOUSE; NONHUMAN;

ANIMALS; ARTERIOSCLEROSIS; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; HEAT; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, LDL; TIME FACTORS;

CHLAMYDIA; CHLAMYDOPHILA PNEUMONIAE; MURINAE;

EID: 4344564832     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:MCBI.0000026066.64125.71     Document Type: Article

References (26)

1. Grayston JT, Kuo CC, Coulson AS, Campbell LA, Lawrence RD, Lee MJ, Strandness ED, Wang SP: Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery (see comments). Circulation 92: 3397-3400, 1995
2. Saikku P, Leinonen M, Mattila K, Ekman MR, Nieminen MS, Makela PH, Huttunen JK, Valtonen V: Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 2: 983-986, 1988
3. Puolakkainen M, Kuo CC, Shor A, Wang SP, Grayston JT, Campbell LA: Serological response to Chlamydia pneumoniae in adults with coronary arterial fatty streaks and fibrolipid plaques. J Clin Microbiol 31: 2212-2214, 1993
4. Ong G, Thomas BJ, Mansfield AO, Davidson BR, Taylor-Robinson D: Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications. J Clin Pathol 49: 102-106, 1996
5. Kuo CC, Grayston JT, Campbell LA, Goo YA, Wissler RW, Benditt EP: Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). Proc Natl Acad Sci USA 92: 6911-6914, 1995
6. Ramirez JA: Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia pneumoniae/Atherosclerosis Study Group. Ann Intern Med 125: 979-982, 1996
7. Kalayoglu MV, Perkins BN, Byrne GI: Chlamydia pneumoniae-infected monocytes exhibit increased adherence to human aortic endothelial cells. Microbes Infect 3: 963-969, 2001
8. Mahdi OS, Horne BD, Mullen K, Muhlestein JB, Byrne GI: Serum immumoglobulin G antibodies to chlamydial heat shock protein 60 but not to human and bacterial homologs are associated with coronary artery disease. Circulation 106: 1659-1663, 2002
9. Fong IW, Chiu B, Viira E, Tucker W, Wood H, Peeling RW: Chlamydial heat-shock protein-60 antibody and correlation with Chlamydia pneumoniae in atherosclerotic plaques. J Infect Dis 186: 1469-1473, 2002
10. Fong IW, Chiu B, Viira E, Fong MW, Jang D, Mahony J: Rabbit model for Chlamydia pneumoniae infection. J Clin Microbiol 35: 48-52, 1997
11. Muhlestein JB: Chlamydia pneumoniae-induced atherosclerosis in a rabbit model. J Infect Dis 181(suppl 3): S505-S507, 2000
12. Hu H, Pierce GN, Zhong G: The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae. J Clin Invest 103: 747-753, 1999
13. Campbell LA, Kuo C: Mouse models of Chlamydia pneumoniae infection and atherosclerosis. Am Heart J 138: S516-S518, 1999
14. Moazed TC, Campbell LA, Rosenfeld ME, Grayston JT, Kuo CC: Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. J Infect Dis 180: 238-41, 1999
15. Liu L, Hu H, Ji H, Murdin AD, Pierce GN, Zhong G: Chlamydia pneumoniae infection significantly exacerbates aortic atherosclerosis in an LDLR-/- mouse model within 6 months. Mol Cell Biochem 215: 123-128, 2001
16. Blessing E, Campbell LA, Rosenfeld ME, Chough N, Kuo CC: Chlamydia pneumoniae infection accelerates hyperlipidemia induced atherosclerotic lesion development in C57BL/6J mice. Atherosclerosis 158: 13-17, 2001
17. Zhong G, Fan P, Ji H, Dong F, Huang Y: Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors. J Exp Med 193: 935-942, 2001
18. Bird DA, Tangirala RK, Fruebis J, Steinberg D, Witztum JL, Palinski W: Effect of probucol on LDL oxidation and atherosclerosis in LDL receptor-deficient mice. J Lipid Res 39: 1079-1090, 1998
19. Tangirala RK, Rubin EM, Palinski W: Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. J Lipid Res 36: 2320-2328, 2002
20. Fong IW, Chiu B, Viira E, Jang D, Mahony JB: Influence of clarithromycin on early atherosclerotic lesions after Chlamydia pneumoniae infection in a rabbit model. Antimicrob Agents Chemother 46: 2321-2326, 2002
21. Yang J, Hooper WC, Phillips DJ, Tondella ML, Talkington DF: Induction of proinflammatory cytokines in human lung epithelial cells during Chlamydia pneumoniae infection. Infect Immun 71: 614-620, 2003
22. Donath B, Fischer C, Page S, Prebeck S, Jilg N, Weber M, da Costa C, Neumeier D, Miethke T, Brand K. Chlamydia pneumoniae activates IKK/I kappa B-mediated signaling, which is inhibited by 4-HNE and following primary exposure. Atherosclerosis 165: 79-88, 2002
23. Netea MG, Kullberg BJ, Galama JM, Stalenhoef AF, Dinarello CA, Van der Meer JW: Non-LPS components of Chlamydia pneumoniae stimulate cytokine production through Toll-like receptor 2-dependent pathways. Eur J Immunol 32:1188-1195, 2002
24. LaVerda D, Kalayoglu MV, Byrne GI. Chlamydial heat shock proteins and disease pathology: new paradigms for old problems? Infect Dis Obstet Gynecol 7: 64-71, 1999
25. Gerdes VE, Verkooyen RP, Kwa VI, de Groot E, van Gorp EC, ten Cate H, Brandjes DP, Buller HR: Chlamydial LPS antibodies, intima-media thickness and ischemic events in patients with established atherosclerosis. Atherosclerosis 167: 65-71, 2003
26. Kalayoglu MV, Byrne GI: A Chlamydia pneumoniae component that induces macrophage foam cell formation is chlamydial lipopolysaccharide. Infect Immun 66: 5067-5072, 1998